Consolidated Statement Of Profit Or Loss

ONO PHARMACEUTICAL CO., LTD. - Filing #7330506

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
502,672,000,000 JPY
447,187,000,000 JPY
Cost of sales
127,126,000,000 JPY
110,062,000,000 JPY
Gross profit
375,547,000,000 JPY
337,124,000,000 JPY
Selling, general and administrative expenses
100,270,000,000 JPY
89,486,000,000 JPY
Other income
1,176,000,000 JPY
734,000,000 JPY
Other expenses
4,343,000,000 JPY
11,065,000,000 JPY
Operating profit (loss)
159,935,000,000 JPY
141,963,000,000 JPY
Finance income
4,027,000,000 JPY
2,478,000,000 JPY
Finance costs
229,000,000 JPY
913,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
1,000,000 JPY
4,000,000 JPY
Profit (loss) before tax
163,734,000,000 JPY
143,532,000,000 JPY
Income tax expense
35,694,000,000 JPY
30,619,000,000 JPY
Profit (loss)
127,977,000,000 JPY
127,977,000,000 JPY
128,040,000,000 JPY
62,000,000 JPY
190,000,000 JPY
112,723,000,000 JPY
112,723,000,000 JPY
112,913,000,000 JPY
Profit (loss) attributable to
Owners of parent
127,977,000,000 JPY
112,723,000,000 JPY
Non-controlling interests
62,000,000 JPY
190,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
266.61
230.85
Diluted earnings (loss) per share
266.57
230.79

Talk to a Data Expert

Have a question? We'll get back to you promptly.